Table 1.
Variable | CRRT | PD | IHD |
---|---|---|---|
Continuous therapy | Yes | Yes | No |
Hemodynamic stability | Yes | Yes | No |
Fluid balance achieved | Yes, pump controlled | Yes/no, variable | Yes, intermittent |
Easy to perform | No | Yes | No |
Metabolic control | Yes | Yes | Yes, intermittent |
Optimal nutrition | Yes | No | No |
Continuous toxin removal | Yes | No/yes, depends on the nature of the toxin—larger molecules not well cleared | No |
Anticoagulation | Yes, requires continuous anticoagulation | No, anticoagulation not required | Yes/no, intermittent anticoagulation |
Rapid poison removal | Yes/no, depending on patient size and dose | No | Yes |
Stable intracranial pressure | Yes | Yes/no, less predictable than CRRT | Yes/no, less predictable than CRRT |
ICU nursing support | Yes, high level of support | Yes/no, moderate level of support (if frequent, manual cycling can be labor intensive) | No, low level of support |
Dialysis nursing support | Yes/no, institution dependent | Yes/no, institution dependent | Yes |
Patient mobility | No | Yes, if IPD used | No |
Cost | High | Low/moderate. Increases with increased dialysis fluid used | High/moderate |
Vascular access required | Yes | No | Yes |
Recent abdominal surgerya | Yes | No | Yes |
VP shunt | Yes | Yes/no, relative contraindication | Yes |
Prune belly syndrome | Yes | Yes/no, relative contraindication | Yes |
Ultrafiltration control | Yes | Yes/no, variable | Yes, intermittent |
PD catheter leakage | No | Yes | No |
Infection potential | Yes | Yes | Yes |
Use in AKI-associated inborn errors of metabolism | Yes | No | Yes |
Use in AKI-associated ingestions | Yes | No | Yes |
aOmphalocele, gastroschisis, frequent or extensive abdominal surgery